Support our work
Decorative header background

Selective serotonin reuptake inhibitors as a novel class of immunosuppressants

Publication year 2014
Published in International Immunopharmacology
Authors Veerle Gobin, Katleen Van Steendam, D. Denys, Dieter Deforce

In the past decades, selective serotonin reuptake inhibitors (SSRIs) have been shown to exert several immunological effects, such as reduced lymphocyte proliferation, alteration of cytokine secretion and induction of apoptosis. Based on these effects, SSRIs were proposed as drugs for the treatment of autoimmune pathologies and graft-versus-host disease. This review summarizes preclinical and clinical evidence supporting a role for SSRIs in autoimmune diseases and graft-versus-host disease, and discusses what is known about the mechanism underlying these effects.

Support our work!

The Friends Foundation facilitates groundbreaking brain research. You can help us with that.

Support our work